Skip to main content

Table 3 Determinants of LV dysfunction in RCM patients

From: Effects of diabetes mellitus on left ventricular function and deformation in patients with restrictive cardiomyopathies: a 3.0T CMR feature tracking study

 

LVEF

LVMI

LVMVR

Univariable

Multivariable

Univariable

Multivariable

Univariable

Multivariable

r

p

β

p

r

p

β

p

Age, years

0.017

0.819

  

0.012

0.870

  

− 0.023

0.761

  

Male, n (%)

− 0.034

0.649

  

− 0.113

0.128

  

− 0.155

0.037

− 0.182

0.010

BMI, kg/m2

0.124

0.094

  

− 0.064

0.393

  

− 0.051

0.492

  

Hyperlipidemia

0.070

0.348

  

0.003

0.972

  

0.075

0.314

  

Hypertension

− 0.099

0.185

  

0.064

0.390

  

0.008

0.920

  

DM

− 0.150

0.043

− 0.166

0.014

− 0.071

0.228

  

− 0.069

0.356

  

eGFR, mL/min/1.73m2

0.069

0.395

  

0.015

0.851

  

0.009

0.393

  

NT-proBNPa

− 0.371

< 0.001

− 0.260

< 0.001

0.328

< 0.001

0.314

< 0.001

0.350

< 0.001

0.272

< 0.001

LGE type

0.399

< 0.001

− 0.297

< 0.001

0.238

< 0.001

  

0.287

< 0.001

0.158

0.037

  1. DM diabetes mellitus, RCM restrictive cardiomyopathy, BMI body mass index, BP blood pressure, NYHA New York Heart Association, HbA1c glycated hemoglobin,; eGFR estimated glomerular filtration rate, LVEDVi left ventricular end diastolic volume index, LVESVi left ventricular end systolic volume index, LVSVi left ventricular stroke volume index, LVEF left ventricular ejection fraction, LVMI left ventricular mass index, LVGFI left ventricular global function index, GPS global peak strain, PSSR peak systolic strain rate, PDSR peak diastolic strain rate, LGE late gadolinium enhancement
  2. aNT-proBNP was log-transformed before being included in the regression analysis